March 19, 2022 Journal article Open Access

Fotouhi, Maryam; Alshafie, Walaa; shlaifer, Irina; Ayoubi, Riham; Durcan, Thomas M.; McPherson, Peter S.; Laflamme, Carl

JSON-LD (schema.org) Export

{
  "inLanguage": {
    "alternateName": "eng", 
    "@type": "Language", 
    "name": "English"
  }, 
  "description": "<p>Head-to-head comparison of available commercial antibodies against Charged multivesicular body protein 2b by immunoblot (Western blot), immunoprecipitation and immunofluorescence. Work reported in this report&nbsp;was supported in part by the ALS-Reproducible Antibody Platform (ALS-RAP). ALS-RAP&nbsp;was created as a public-private partnership by three leading ALS charities - the ALS Association (USA), the Motor Neurone Disease Association (UK), and the ALS Society of Canada.</p>", 
  "license": "https://creativecommons.org/licenses/by/4.0/legalcode", 
  "creator": [
    {
      "affiliation": "Montreal Neurological Institute", 
      "@id": "https://orcid.org/0000-0001-8937-4719", 
      "@type": "Person", 
      "name": "Fotouhi, Maryam"
    }, 
    {
      "affiliation": "Montreal Neurological Institute", 
      "@id": "https://orcid.org/0000-0001-7999-1297", 
      "@type": "Person", 
      "name": "Alshafie, Walaa"
    }, 
    {
      "affiliation": "Montreal Neurological Institute", 
      "@id": "https://orcid.org/0000-0002-3737-268X", 
      "@type": "Person", 
      "name": "shlaifer, Irina"
    }, 
    {
      "affiliation": "Montreal Neurological Institute", 
      "@id": "https://orcid.org/0000-0001-6633-655X", 
      "@type": "Person", 
      "name": "Ayoubi, Riham"
    }, 
    {
      "affiliation": "Montreal Neurological Institute", 
      "@id": "https://orcid.org/0000-0003-3942-1956", 
      "@type": "Person", 
      "name": "Durcan, Thomas M."
    }, 
    {
      "affiliation": "Montreal Neurological Institute", 
      "@id": "https://orcid.org/0000-0001-7806-5662", 
      "@type": "Person", 
      "name": "McPherson, Peter S."
    }, 
    {
      "affiliation": "Montreal Neurological Institute", 
      "@id": "https://orcid.org/0000-0001-5906-025X", 
      "@type": "Person", 
      "name": "Laflamme, Carl"
    }
  ], 
  "headline": "Antibody Characterization Report for Charged multivesicular body protein 2b", 
  "image": "https://zenodo.org/static/img/logos/zenodo-gradient-round.svg", 
  "datePublished": "2022-03-19", 
  "url": "https://zenodo.org/record/6370501", 
  "keywords": [
    "Charged multivesicular body protein 2b", 
    "Chromatin-modifying protein 2b", 
    "Vacuolar protein sorting-associated protein 2-2", 
    "Vps2-2", 
    "CHMP2B", 
    "Q9UQN3", 
    "antibody validation", 
    "antibody characterization", 
    "YCharOS", 
    "ALS-RAP", 
    "amyotrophic lateral sclerosis"
  ], 
  "@context": "https://schema.org/", 
  "identifier": "https://doi.org/10.5281/zenodo.6370501", 
  "@id": "https://doi.org/10.5281/zenodo.6370501", 
  "@type": "ScholarlyArticle", 
  "name": "Antibody Characterization Report for Charged multivesicular body protein 2b"
}